Vitamin B12 deficiency is associated with adverse lipid profile in Europeans and Indians with type 2 diabetes

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Adaikalakoteswari, Antonysunil ^a   Jayashri, Ramamurthy ^b   Sukumar, Nithya ^a   Venkataraman, Hema ^a   Pradeepa, Rajendra ^b   Gokulakrishnan, Kuppan ^b   Anjana, Ranjit M ^b   McTernan, Philip G ^a   Tripathi, Gyanendra ^a   Patel, Vinod ^c   Kumar, Sudhesh ^a,d   Mohan, Viswanathan ^b   Saravanan, Ponnusamy ^a,c,d  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b MADRAS DIABETES RESEARCH FOUNDATION   (India)

^c GEORGE ELIOT HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; METFORMIN; TRIACYLGLYCEROL; ANTIDIABETIC AGENT;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; CYANOCOBALAMIN DEFICIENCY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; ETHNIC DIFFERENCE; EUROPEAN; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; INDIA; INDIAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PREVALENCE; RETINOPATHY; SMOKING; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM; VITAMIN BLOOD LEVEL; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COMPLICATION; DIABETES MELLITUS, TYPE 2; EUROPE; GENETICS; LIPID METABOLISM; METABOLISM; MIDDLE AGED; RISK FACTOR; VERY ELDERLY; VITAMIN B 12 DEFICIENCY;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; EUROPE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INDIA; LIPID METABOLISM; MALE; METFORMIN; MIDDLE AGED; PREVALENCE; RISK FACTORS; VITAMIN B 12 DEFICIENCY;

EID: 84908067854     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-014-0129-4     Document Type: Article

References (42)

1. McNulty H, Pentieva K, Hoey L, Ward M. Homocysteine, B-vitamins and CVD. Proc Nutr Soc 2008, 67(2):232-237. 10.1017/S0029665108007076, 18412997.
2. Ng KC, Yong QW, Chan SP, Cheng A. Homocysteine, folate and vitamin B12 as risk factors for acute myocardial infarction in a Southeast Asian population. Ann Acad Med Singap 2002, 31(5):636-640. 12395652.
3. Weikert C, Dierkes J, Hoffmann K, Berger K, Drogan D, Klipstein-Grobusch K, Spranger J, Mohlig M, Luley C, Boeing H. B vitamin plasma levels and the risk of ischemic stroke and transient ischemic attack in a German cohort. Stroke 2007, 38(11):2912-2918. 10.1161/STROKEAHA.107.486068, 17885260.
4. Mahalle N, Kulkarni MV, Garg MK, Naik SS. Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease. J Cardiol 2013, 61(4):289-294. 10.1016/j.jjcc.2012.11.009, 23473764.
5. Rafnsson SB, Saravanan P, Bhopal RS, Yajnik CS. Is a low blood level of vitamin B12 a cardiovascular and diabetes risk factor? A systematic review of cohort studies. Eur J Nutr 2011, 50(2):97-106. 10.1007/s00394-010-0119-6, 20585951.
6. McCombe PA, McLeod JG. The peripheral neuropathy of vitamin B12 deficiency. J Neurol Sci 1984, 66(1):117-126. 10.1016/0022-510X(84)90147-3, 6097649.
7. Solomon LR. Diabetes as a cause of clinically significant functional cobalamin deficiency. Diabetes Care 2011, 34(5):1077-1080. 10.2337/dc11-0009, 21421801.
8. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012, 55(6):1577-1596. 10.1007/s00125-012-2534-0, 22526604.
9. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012, 35(6):1364-1379. 10.2337/dc12-0413, 22517736.
10. de Jager J, Kooy A, Lehert P, Wulffele MG, van der Kolk J, Bets D, Verburg J, Donker AJ, Stehouwer CD. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ 2010, 340:c2181. 10.1136/bmj.c2181, 20488910.
11. Reinstatler L, Qi YP, Williamson RS, Garn JV, Oakley GP. Association of biochemical B(1)(2) deficiency with metformin therapy and vitamin B(1)(2) supplements: the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care 2012, 35(2):327-333. 10.2337/dc11-1582, 22179958.
12. Beulens JW, Hart HE, Kuijs R, Kooijman-Buiting AM, Rutten GE: Influence of duration and dose of metformin on cobalamin deficiency in type 2 diabetes patients using metformin.Acta Diabetol 2014, [Epub ahead of print].
13. Pflipsen MC, Oh RC, Saguil A, Seehusen DA, Seaquist D, Topolski R. The prevalence of vitamin B(12) deficiency in patients with type 2 diabetes: a cross-sectional study. J Am Board Fam Med 2009, 22(5):528-534. 10.3122/jabfm.2009.05.090044, 19734399.
14. Stabler SP. Vitamin B12 deficiency. N Engl J Med 2013, 368(21):2041-2042. 23697526.
15. Tillin T, Forouhi N, Johnston DG, McKeigue PM, Chaturvedi N, Godsland IF. Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study. Diabetologia 2005, 48(4):649-656. 10.1007/s00125-005-1689-3, 15759110.
16. Tillin T, Hughes AD, Mayet J, Whincup P, Sattar N, Forouhi NG, McKeigue PM, Chaturvedi N. The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans: SABRE (Southall and Brent Revisited) - a prospective population-based study. J Am Coll Cardiol 2013, 61(17):1777-1786. 10.1016/j.jacc.2012.12.046, 23500273.
17. McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG. Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation 1993, 87(1):152-161. 10.1161/01.CIR.87.1.152, 8419002.
18. Yajnik CS, Deshpande SS, Lubree HG, Naik SS, Bhat DS, Uradey BS, Deshpande JA, Rege SS, Refsum H, Yudkin JS. Vitamin B12 deficiency and hyperhomocysteinemia in rural and urban Indians. J Assoc Physicians India 2006, 54:775-782. 17214273.
19. Saravanan P, Yajnik CS. Role of maternal vitamin B12 on the metabolic health of the offspring: a contributor to the diabetes epidemic?. Br J Diab Vascular Dis 2010, 10:109-114. 10.1177/1474651409358015.
20. Howard AJ, Kulkarni O, Lekwuwa G, Emsley HC. Rapidly progressive polyneuropathy due to dry beriberi in a man: a case report. J Med Case Rep 2010, 4:409. 10.1186/1752-1947-4-409, 21176139.
21. Wasilewska A, Narkiewicz M, Rutkowski B, Lysiak-Szydlowska W. Is there any relationship between lipids and vitamin B levels in persons with elevated risk of atherosclerosis?. Med Sci Monit 2003, 9(3):CR147-CR151. 12640345.
22. Wulffele MG, Kooy A, Lehert P, Bets D, Ogterop JC, Borger van der Burg B, Donker AJ, Stehouwer CD. Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med 2003, 254(5):455-463. 10.1046/j.1365-2796.2003.01213.x, 14535967.
23. Refsum H, Yajnik CS, Gadkari M, Schneede J, Vollset SE, Orning L, Guttormsen AB, Joglekar A, Sayyad MG, Ulvik A, Ueland PM. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr 2001, 74(2):233-241. 11470726.
24. Iyer BK, Singhal RS, Ananthanarayan L. Characterization and in vitro probiotic evaluation of lactic acid bacteria isolated from idli batter. J Food Sci Technol 2013, 50(6):1114-1121. 10.1007/s13197-011-0445-6, 24426023.
25. Madhu AN, Giribhattanavar P, Narayan MS, Prapulla SG. Probiotic lactic acid bacterium from kanjika as a potential source of vitamin B12: evidence from LC-MS, immunological and microbiological techniques. Biotechnol Lett 2010, 32(4):503-506. 10.1007/s10529-009-0176-1, 19953302.
26. Strain JJ, Dowey L, Ward M, Pentieva K, McNulty H. B-vitamins, homocysteine metabolism and CVD. Proc Nutr Soc 2004, 63(4):597-603. 10.1079/PNS2004390, 15831132.
27. Rosenberg IH. Metabolic programming of offspring by vitamin B12/folate imbalance during pregnancy. Diabetologia 2008, 51(1):6-7. 10.1007/s00125-007-0869-8, 18034225.
28. Brindle NP, Zammit VA, Pogson CI. Regulation of carnitine palmitoyltransferase activity by malonyl-CoA in mitochondria from sheep liver, a tissue with a low capacity for fatty acid synthesis. Biochem J 1985, 232(1):177-182. 4084227.
29. Shargorodsky M, Boaz M, Pasternak S, Hanah R, Matas Z, Fux A, Beigel Y, Mashavi M. Serum homocysteine, folate, vitamin B12 levels and arterial stiffness in diabetic patients: which of them is really important in atherogenesis?. Diabetes Metab Res Rev 2009, 25(1):70-75. 10.1002/dmrr.902, 19065546.
30. Chackathayil J, Patel JV, Gill PS, Potluri R, Natalwala A, Uppal H, Lavu D, Heun R, Hughes EA, Lip GY. Cardiovascular Risk Profiles amongst Women in a Multiethnic Population in Inner City Britain: A Potential Impact of Anaemia. Int J Endocrinol 2013, 2013:303859. 10.1155/2013/303859, 23509453.
31. Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA 2008, 299(17):2027-2036. 10.1001/jama.299.17.2027, 18460663.
32. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004, 291(5):565-575. 10.1001/jama.291.5.565, 14762035.
33. Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y, Sun N, Liu L, Xu X. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 2007, 369(9576):1876-1882. 10.1016/S0140-6736(07)60854-X, 17544768.
34. Alkharfy KM, Al-Daghri NM, Sabico SB, Al-Othman A, Moharram O, Alokail MS, Al-Saleh Y, Kumar S, Chrousos GP. Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study. Cardiovasc Diabetol 2013, 12:113. 10.1186/1475-2840-12-113, 23924389.
35. Kelly AS, Bergenstal RM, Gonzalez-Campoy JM, Katz H, Bank AJ. Effects of exenatide vs. metformin on endothelial function in obese patients with pre-diabetes: a randomized trial. Cardiovasc Diabetol 2012, 11:64. 10.1186/1475-2840-11-64, 22681705.
36. Ruckert IM, Schunk M, Holle R, Schipf S, Volzke H, Kluttig A, Greiser KH, Berger K, Muller G, Ellert U, Neuhauser H, Rathmann W, Tamayo T, Moebus S, Andrich S, Meisinger C. Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies. Cardiovasc Diabetol 2012, 11:50. 10.1186/1475-2840-11-50, 22569118.
37. Vaya A, Carmona P, Badia N, Perez R, Hernandez Mijares A, Corella D. Homocysteine levels and the metabolic syndrome in a Mediterranean population: a case-control study. Clin Hemorheol Microcirc 2011, 47(1):59-66. 21321409.
38. Russo GT, Giandalia A, Romeo EL, Marotta M, Alibrandi A, De Francesco C, Horvath KV, Asztalos B, Cucinotta D. Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease. J Endocrinol Investig 2014, 37(3):261-268. 10.1007/s40618-013-0023-z.
39. Sahin M, Tutuncu NB, Ertugrul D, Tanaci N, Guvener ND. Effects of metformin or rosiglitazone on serum concentrations of homocysteine, folate, and vitamin B12 in patients with type 2 diabetes mellitus. J Diabetes Complicat 2007, 21(2):118-123. 10.1016/j.jdiacomp.2005.10.005, 17331860.
40. Diakoumopoulou E, Tentolouris N, Kirlaki E, Perrea D, Kitsou E, Psallas M, Doulgerakis D, Katsilambros N. Plasma homocysteine levels in patients with type 2 diabetes in a Mediterranean population: relation with nutritional and other factors. Nutr Metab Cardiovasc Dis 2005, 15(2):109-117. 10.1016/j.numecd.2004.01.001, 15871859.
41. Gonzalez R, Pedro T, Real JT, Martinez-Hervas S, Abellan MR, Lorente R, Priego A, Catala M, Chaves FJ, Ascaso JF, Carmena R. Plasma homocysteine levels are associated with ulceration of the foot in patients with type 2 diabetes mellitus. Diabetes Metab Res Rev 2010, 26(2):115-120. 10.1002/dmrr.1061, 20135633.
42. El Harchaoui K, van der Steeg WA, Stroes ES, Kuivenhoven JA, Otvos JD, Wareham NJ, Hutten BA, Kastelein JJ, Khaw KT, Boekholdt SM. Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 2007, 49(5):547-553. 10.1016/j.jacc.2006.09.043, 17276177.